Results
4094
Companies which are more than 50% undervalued based on analyst price target.
4,094 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
XMR | SEK 0.017 | -2.9% | -95.8% | SEK 10.2m | SEK 0.11 | PS0.4x | E71.0% | n/a | Software | ||
SONX | US$2.13 | -9.4% | -93.3% | US$907.9k | US$30.00 | PS0.02x | E21.8% | n/a | Healthcare | ||
GIAB | SEK 0.56 | 3.7% | -66.3% | SEK 8.7m | SEK 2.40 | PS0.06x | E59.3% | n/a | Commercial Services | ||
WYLD | SEK 0.015 | 10.0% | -99.7% | SEK 8.2m | SEK 14.00 | PS5x | S81.3% | n/a | Telecom | ||
LLAI | UK£0.018 | -82.4% | -96.0% | UK£551.9k | UK£1.71 | PS23.7x | E101.0% | n/a | Pharmaceuticals & Biotech | ||
CHF | UK£0.0037 | -6.3% | -16.7% | UK£488.7k | UK£0.21 | PB0.7x | n/a | n/a | Materials | ||
JZ6 | €0.30 | 0% | -81.1% | €553.5k | €6.50 | PS0.06x | S14.7% | n/a | Consumer Durables | ||
BIOR.Q | US$0.15 | 19.6% | -98.2% | US$520.6k | US$34.00 | PS0.7x | E-21.5% | n/a | Pharmaceuticals & Biotech | ||
SOZAP | SEK 0.22 | 2.8% | -96.5% | SEK 4.9m | SEK 3.50 | PS0.2x | S16.9% | n/a | Media | ||
ZPTA | US$0.01 | 0% | -99.9% | US$386.3k | US$1.75 | PS0.06x | E48.8% | n/a | Software | ||
CYTO.F | US$0.11 | -0.09% | -94.1% | US$374.2k | US$5.29 | PB0.06x | E-4.4% | n/a | Pharmaceuticals & Biotech | ||
NGENIC | SEK 0.47 | -14.3% | -96.2% | SEK 3.2m | SEK 18.00 | PS0.07x | E42.2% | n/a | Tech | ||
ALSPW | €0.091 | 0.9% | -99.1% | €75.6k | €1.30 | PS0.006x | E107.6% | n/a | Healthcare | ||
SHWZ | US$0.000001 | -100.0% | -100.0% | US$80.0 | US$2.64 | PB0.000001x | S6.4% | n/a | Pharmaceuticals & Biotech |